Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Nephropharmacology is Scopus-indexed (Q3, CiteScore 1.2), DOAJ. Published by Society of Diabetic Nephropathy Prevention.
Checked against the index lists dated .
ISSN 2345-4202Verify ISSN ↗
Publisher: Society of Diabetic Nephropathy Prevention
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Nephrology | 62 / 88 | 30th | Q3 |
| Pharmacology (medical) | 209 / 278 | 25th | Q3 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q3, CiteScore 1.2.
Journal of Nephropharmacology is Q3 in Nephrology (rank 62 of 88) and Q3 in Pharmacology (medical) (rank 209 of 278), by CiteScore 2025.
Journal of Nephropharmacology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.2, quartile Q3, 30th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.196, quartile Q3, with an H-index of 9.
Journal of Nephropharmacology is published by Society of Diabetic Nephropathy Prevention. Its ISSN is 2345-4202.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Journal of Nephropharmacology has an h-index of 11 and a 2-year mean of 0.71 citations per paper (OpenAlex). Its Scopus CiteScore is 1.2, quartile Q3. On 2-year citations it ranks #59 of 87 Scopus journals in Nephrology.
Journal of Nephropharmacology published 21 papers in 2025; its busiest recent year was 2019 with 39. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2022–2026), authors are most often from Iran (61.7%), Iraq (11.3%) and India (8.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.